Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
371935-74-9
|
| gptkbp:hasInChIKey |
QJQYQKZKJXJZQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C19H22F2N6O3
|
| gptkbp:hasRole |
investigational drug
|
| gptkbp:hasSMILES |
CN(C)C(=O)Nc1c(N2CCOCC2)nc(OC(F)F)nc1C
|
| https://www.w3.org/2000/01/rdf-schema#label |
PI-103
|
| gptkbp:inhibitedBy |
gptkb:DNA-PK
gptkb:PI3K gptkb:mTOR |
| gptkbp:is_not_approved_for_clinical_use |
true
|
| gptkbp:IUPACName |
gptkb:N'-[2-(difluoromethoxy)-6-methyl-4-(4-morpholinyl)pyrimidin-5-yl]-N,N-dimethylurea
|
| gptkbp:molecularWeight |
420.41 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL449153
11364421 9542472 |
| gptkbp:target |
gptkb:mTORC1
gptkb:mTORC2 gptkb:class_I_PI3K |
| gptkbp:used_in |
cancer research
|
| gptkbp:usedFor |
tool compound
|
| gptkbp:bfsParent |
gptkb:phosphoinositide_3-kinase/AKT_pathway
|
| gptkbp:bfsLayer |
6
|